A peer-reviewed breakdown of the six peptides most studied for anabolic signaling, muscle repair, and body composition research — including mechanism of action, comparative analysis, and dosing protocols from preclinical literature.
Skeletal muscle hypertrophy — the increase in muscle fiber cross-sectional area — is governed by a complex interplay of mechanical loading signals, hormonal environment, and cellular repair mechanisms. At the hormonal level, growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are the primary anabolic drivers. GH stimulates hepatic IGF-1 production; IGF-1 then acts on muscle satellite cells and myofibers to promote protein synthesis, nitrogen retention, and muscle fiber repair.
The peptides studied in this context fall into two broad categories: growth hormone secretagogues (GHSs) — which stimulate the pituitary to release endogenous GH — and tissue repair peptides — which act directly on connective tissue, vasculature, and inflammatory pathways to accelerate recovery and maintain structural integrity under training stress.
Stimulate pituitary GH release → hepatic IGF-1 production → muscle protein synthesis, satellite cell activation, nitrogen retention. Examples: CJC-1295, Ipamorelin, Sermorelin, Tesamorelin.
Act directly on connective tissue, vasculature, and inflammatory pathways. Accelerate recovery from muscle and tendon injury. Examples: TB-500 (Thymosin Beta-4), BPC-157.
The big picture: Your body already makes growth hormone — it's what drives muscle repair and growth after exercise. The problem is that GH production declines significantly after your mid-20s. The peptides on this page work by telling your pituitary gland to release more of your own GH, in a natural pulsatile pattern. They don't add synthetic hormones to your body; they stimulate your body to produce more of what it already makes.
The two categories, simply: Think of it like a two-part system. The first category (CJC-1295, Ipamorelin, Sermorelin) are like pressing the "release" button on your pituitary gland — they trigger GH pulses. The second category (TB-500, BPC-157) are like a repair crew — they work directly at the site of muscle and tendon damage to speed up healing. Many research protocols combine both approaches.
Why CJC-1295 + Ipamorelin are often studied together: They work through completely different receptors, so combining them produces a stronger GH pulse than either alone. It's like pressing two different "on" buttons simultaneously. CJC-1295 has a long half-life (days), so it provides a steady background signal. Ipamorelin has a short half-life (hours), so it creates sharp GH spikes on top of that baseline.
Bottom line: These aren't steroids. They don't add hormones from outside — they signal your own body to produce more of what it already makes, in a more natural pattern. That's the key distinction that makes this class of compounds so interesting to researchers.
Ranked by breadth of preclinical literature on anabolic and recovery signaling.
Binds GHRH receptor in pituitary, stimulating sustained GH release. DAC version has ~8-day half-life via albumin binding.
Activates ghrelin receptor (GHS-R1a) to stimulate pulsatile GH release. Highly selective — minimal cortisol or prolactin elevation.
29-AA fragment of endogenous GHRH. Stimulates pituitary GH release in a physiologically normal pulsatile pattern. Short half-life requires daily dosing.
Binds G-actin monomers, regulating actin dynamics. Promotes satellite cell migration, angiogenesis, and anti-inflammatory signaling in damaged muscle.
Upregulates VEGFR2-mediated angiogenesis and Egr-1 transcription. Promotes fibroblast migration and tendon-to-bone healing in preclinical models.
Stabilized GHRH analogue with trans-3-hexenoic acid modification. Stimulates GH release and has been studied for body composition changes including visceral fat reduction.
| Compound | Mechanism | Half-Life | Dosing Freq. | Primary Use | Stack Synergy |
|---|---|---|---|---|---|
| CJC-1295 | GHRH-R agonist | ~8 days (DAC) | 2–3× / week | GH elevation | Ipamorelin |
| Ipamorelin | GHS-R1a agonist | ~2 hours | 2–3× / day | Pulsatile GH | CJC-1295 |
| Sermorelin | GHRH-R agonist | ~10 min | Once daily | Natural GH pattern | Ipamorelin |
| TB-500 | Actin-binding | ~96 hours | 2× / week | Muscle repair | BPC-157 |
| BPC-157 | VEGFR2 / Egr-1 | ~4 hours | 1–2× / day | Connective tissue | TB-500 |
| Tesamorelin | GHRH-R agonist | ~8 min | Once daily | Body composition | Ipamorelin |
The hypothalamic-pituitary-somatotropic axis governs endogenous growth hormone secretion. The hypothalamus releases GHRH (growth hormone-releasing hormone) in a pulsatile pattern, stimulating the anterior pituitary to secrete GH. GH then acts on the liver and peripheral tissues to stimulate IGF-1 production. IGF-1 is the primary mediator of GH's anabolic effects on skeletal muscle.
Growth hormone secretagogue peptides exploit this axis by either mimicking GHRH (CJC-1295, Sermorelin, Tesamorelin) or activating the ghrelin receptor to stimulate GH release through a complementary pathway (Ipamorelin). The key advantage of secretagogue-based approaches over exogenous GH administration is that they preserve the pulsatile, physiologically normal pattern of GH release — which is important for maintaining receptor sensitivity and avoiding the desensitization associated with continuous GH exposure.
"The combination of a GHRH analogue with a GHRP produces a synergistic GH pulse approximately 3–5 times greater than either agent alone — a finding consistently replicated across multiple preclinical and early clinical studies."
— Sigalos & Pastuszak, Sexual Medicine Reviews, 2018
CJC-1295, Ipamorelin, Sermorelin, TB-500, BPC-157, and Tesamorelin — all available with ≥99% purity and third-party COA verification.
View All Compounds at Purgo LabsUse code Health for 15% off · For research purposes only
Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.